1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Next Generation Vector Engineering Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Next Generation Vector Engineering Market, by Vector Type
8.1.1. Viral Vectors
8.1.1.1. Market Revenue and Forecast
8.1.2. Non-viral Vectors
8.1.2.1. Market Revenue and Forecast
8.1.3. Synthetic & Engineered Vectors
8.1.3.1. Market Revenue and Forecast
9.1. Next Generation Vector Engineering Market, by Technology Approach
9.1.1. Capsid Engineering
9.1.1.1. Market Revenue and Forecast
9.1.2. Payload Engineering
9.1.2.1. Market Revenue and Forecast
9.1.3. Targeting & Tropism Engineering
9.1.3.1. Market Revenue and Forecast
9.1.4. Immunogenicity Reduction / Stealth Engineering
9.1.4.1. Market Revenue and Forecast
9.1.5. Manufacturability & Scalability Optimization
9.1.5.1. Market Revenue and Forecast
9.1.6. Gene Editing-specific Vectors
9.1.6.1. Market Revenue and Forecast
10.1. Next Generation Vector Engineering Market, by Application
10.1.1. Gene Therapy
10.1.1.1. Market Revenue and Forecast
10.1.2. Cell Therapy
10.1.2.1. Market Revenue and Forecast
10.1.3. Vaccines
10.1.3.1. Market Revenue and Forecast
10.1.4. Genetic Research & Functional Genomics
10.1.4.1. Market Revenue and Forecast
10.1.5. Drug Delivery Research
10.1.5.1. Market Revenue and Forecast
11.1. Next Generation Vector Engineering Market, by Workflow Stage
11.1.1. Discovery & Design
11.1.1.1. Market Revenue and Forecast
11.1.2. Preclinical Development
11.1.2.1. Market Revenue and Forecast
11.1.3. Clinical Manufacturing
11.1.3.1. Market Revenue and Forecast
11.1.4. Commercial Manufacturing
11.1.4.1. Market Revenue and Forecast
12.1. Next Generation Vector Engineering Market, by End User
12.1.1. Biopharmaceutical Companies
12.1.1.1. Market Revenue and Forecast
12.1.2. Academic & Research Institutes
12.1.2.1. Market Revenue and Forecast
12.1.3. Contract Development & Manufacturing Organizations (CDMOs)
12.1.3.1. Market Revenue and Forecast
12.1.4. Contract Research Organizations (CROs)
12.1.4.1. Market Revenue and Forecast
12.1.5. Government & Public Health Research Bodies
12.1.5.1. Market Revenue and Forecast
13.1. Next Generation Vector Engineering Market, by Delivery Route
13.1.1. In vivo Delivery
13.1.1.1. Market Revenue and Forecast
13.1.2. Ex vivo Delivery
13.1.2.1. Market Revenue and Forecast
14.1. North America
14.1.1. Market Revenue and Forecast, by Vector Type
14.1.2. Market Revenue and Forecast, by Technology Approach
14.1.3. Market Revenue and Forecast, by Application
14.1.4. Market Revenue and Forecast, by Workflow Stage
14.1.5. Market Revenue and Forecast, by End User
14.1.6. Market Revenue and Forecast, by Delivery Route
14.1.7. U.S.
14.1.7.1. Market Revenue and Forecast, by Vector Type
14.1.7.2. Market Revenue and Forecast, by Technology Approach
14.1.7.3. Market Revenue and Forecast, by Application
14.1.7.4. Market Revenue and Forecast, by Workflow Stage
14.1.8. Market Revenue and Forecast, by End User
14.1.8.1. Market Revenue and Forecast, by Delivery Route
14.1.9. Rest of North America
14.1.9.1. Market Revenue and Forecast, by Vector Type
14.1.9.2. Market Revenue and Forecast, by Technology Approach
14.1.9.3. Market Revenue and Forecast, by Application
14.1.9.4. Market Revenue and Forecast, by Workflow Stage
14.1.10. Market Revenue and Forecast, by End User
14.1.11. Market Revenue and Forecast, by Delivery Route
14.2. Europe
14.2.1. Market Revenue and Forecast, by Vector Type
14.2.2. Market Revenue and Forecast, by Technology Approach
14.2.3. Market Revenue and Forecast, by Application
14.2.4. Market Revenue and Forecast, by Workflow Stage
14.2.5. Market Revenue and Forecast, by End User
14.2.6. Market Revenue and Forecast, by Delivery Route
14.2.8. UK
14.2.8.1. Market Revenue and Forecast, by Vector Type
14.2.8.2. Market Revenue and Forecast, by Technology Approach
14.2.8.3. Market Revenue and Forecast, by Application
14.2.9. Market Revenue and Forecast, by Workflow Stage
14.2.10. Market Revenue and Forecast, by End User
14.2.10.1. Market Revenue and Forecast, by Delivery Route
14.2.11. Germany
14.2.11.1. Market Revenue and Forecast, by Vector Type
14.2.11.2. Market Revenue and Forecast, by Technology Approach
14.2.11.3. Market Revenue and Forecast, by Application
14.2.12. Market Revenue and Forecast, by Workflow Stage
14.2.13. Market Revenue and Forecast, by End User
14.2.14. Market Revenue and Forecast, by Delivery Route
14.2.15. France
14.2.15.1. Market Revenue and Forecast, by Vector Type
14.2.15.2. Market Revenue and Forecast, by Technology Approach
14.2.15.3. Market Revenue and Forecast, by Application
14.2.15.4. Market Revenue and Forecast, by Workflow Stage
14.2.16. Market Revenue and Forecast, by End User
14.2.16.1. Market Revenue and Forecast, by Delivery Route
14.2.17. Rest of Europe
14.2.17.1. Market Revenue and Forecast, by Vector Type
14.2.17.2. Market Revenue and Forecast, by Technology Approach
14.2.17.3. Market Revenue and Forecast, by Application
14.2.17.4. Market Revenue and Forecast, by Workflow Stage
14.2.18. Market Revenue and Forecast, by End User
14.2.18.1. Market Revenue and Forecast, by Delivery Route
14.3. APAC
14.3.1. Market Revenue and Forecast, by Vector Type
14.3.2. Market Revenue and Forecast, by Technology Approach
14.3.3. Market Revenue and Forecast, by Application
14.3.4. Market Revenue and Forecast, by Workflow Stage
14.3.5. Market Revenue and Forecast, by End User
14.3.6. Market Revenue and Forecast, by Delivery Route
14.3.7. India
14.3.7.1. Market Revenue and Forecast, by Vector Type
14.3.7.2. Market Revenue and Forecast, by Technology Approach
14.3.7.3. Market Revenue and Forecast, by Application
14.3.7.4. Market Revenue and Forecast, by Workflow Stage
14.3.8. Market Revenue and Forecast, by End User
14.3.9. Market Revenue and Forecast, by Delivery Route
14.3.10. China
14.3.10.1. Market Revenue and Forecast, by Vector Type
14.3.10.2. Market Revenue and Forecast, by Technology Approach
14.3.10.3. Market Revenue and Forecast, by Application
14.3.10.4. Market Revenue and Forecast, by Workflow Stage
14.3.11. Market Revenue and Forecast, by End User
14.3.11.1. Market Revenue and Forecast, by Delivery Route
14.3.12. Japan
14.3.12.1. Market Revenue and Forecast, by Vector Type
14.3.12.2. Market Revenue and Forecast, by Technology Approach
14.3.12.3. Market Revenue and Forecast, by Application
14.3.12.4. Market Revenue and Forecast, by Workflow Stage
14.3.12.5. Market Revenue and Forecast, by End User
14.3.12.6. Market Revenue and Forecast, by Delivery Route
14.3.13. Rest of APAC
14.3.13.1. Market Revenue and Forecast, by Vector Type
14.3.13.2. Market Revenue and Forecast, by Technology Approach
14.3.13.3. Market Revenue and Forecast, by Application
14.3.13.4. Market Revenue and Forecast, by Workflow Stage
14.3.13.5. Market Revenue and Forecast, by End User
14.3.13.6. Market Revenue and Forecast, by Delivery Route
14.4. MEA
14.4.1. Market Revenue and Forecast, by Vector Type
14.4.2. Market Revenue and Forecast, by Technology Approach
14.4.3. Market Revenue and Forecast, by Application
14.4.4. Market Revenue and Forecast, by Workflow Stage
14.4.5. Market Revenue and Forecast, by End User
14.4.6. Market Revenue and Forecast, by Delivery Route
14.4.7. GCC
14.4.7.1. Market Revenue and Forecast, by Vector Type
14.4.7.2. Market Revenue and Forecast, by Technology Approach
14.4.7.3. Market Revenue and Forecast, by Application
14.4.7.4. Market Revenue and Forecast, by Workflow Stage
14.4.8. Market Revenue and Forecast, by End User
14.4.9. Market Revenue and Forecast, by Delivery Route
14.4.10. North Africa
14.4.10.1. Market Revenue and Forecast, by Vector Type
14.4.10.2. Market Revenue and Forecast, by Technology Approach
14.4.10.3. Market Revenue and Forecast, by Application
14.4.10.4. Market Revenue and Forecast, by Workflow Stage
14.4.11. Market Revenue and Forecast, by End User
14.4.12. Market Revenue and Forecast, by Delivery Route
14.4.13. South Africa
14.4.13.1. Market Revenue and Forecast, by Vector Type
14.4.13.2. Market Revenue and Forecast, by Technology Approach
14.4.13.3. Market Revenue and Forecast, by Application
14.4.13.4. Market Revenue and Forecast, by Workflow Stage
14.4.13.5. Market Revenue and Forecast, by End User
14.4.13.6. Market Revenue and Forecast, by Delivery Route
14.4.14. Rest of MEA
14.4.14.1. Market Revenue and Forecast, by Vector Type
14.4.14.2. Market Revenue and Forecast, by Technology Approach
14.4.14.3. Market Revenue and Forecast, by Application
14.4.14.4. Market Revenue and Forecast, by Workflow Stage
14.4.14.5. Market Revenue and Forecast, by End User
14.4.14.6. Market Revenue and Forecast, by Delivery Route
14.5. Latin America
14.5.1. Market Revenue and Forecast, by Vector Type
14.5.2. Market Revenue and Forecast, by Technology Approach
14.5.3. Market Revenue and Forecast, by Application
14.5.4. Market Revenue and Forecast, by Workflow Stage
14.5.5. Market Revenue and Forecast, by End User
14.5.6. Market Revenue and Forecast, by Delivery Route
14.5.7. Brazil
14.5.7.1. Market Revenue and Forecast, by Vector Type
14.5.7.2. Market Revenue and Forecast, by Technology Approach
14.5.7.3. Market Revenue and Forecast, by Application
14.5.7.4. Market Revenue and Forecast, by Workflow Stage
14.5.8. Market Revenue and Forecast, by End User
14.5.8.1. Market Revenue and Forecast, by Delivery Route
14.5.9. Rest of LATAM
14.5.9.1. Market Revenue and Forecast, by Vector Type
14.5.9.2. Market Revenue and Forecast, by Technology Approach
14.5.9.3. Market Revenue and Forecast, by Application
14.5.9.4. Market Revenue and Forecast, by Workflow Stage
14.5.9.5. Market Revenue and Forecast, by End User
14.5.9.6. Market Revenue and Forecast, by Delivery Route
15.1. Catalent, Inc.
15.1.1. Company Overview
15.1.2. Product Offerings
15.1.3. Financial Performance
15.1.4. Recent Initiatives
15.2. Thermo Fisher Scientific
15.2.1. Company Overview
15.2.2. Product Offerings
15.2.3. Financial Performance
15.2.4. Recent Initiatives
15.3. WuXi Advanced Therapies
15.3.1. Company Overview
15.3.2. Product Offerings
15.3.3. Financial Performance
15.3.4. Recent Initiatives
15.4. Lonza Group AG
15.4.1. Company Overview
15.4.2. Product Offerings
15.4.3. Financial Performance
15.4.4. Recent Initiatives
15.5. AGC Biologics
15.5.1. Company Overview
15.5.2. Product Offerings
15.5.3. Financial Performance
15.5.4. Recent Initiatives
15.6. Takara Bio
15.6.1. Company Overview
15.6.2. Product Offerings
15.6.3. Financial Performance
15.6.4. Recent Initiatives
15.7. Vigene Biosciences
15.7.1. Company Overview
15.7.2. Product Offerings
15.7.3. Financial Performance
15.7.4. Recent Initiatives
15.8. Vector BioPharma
15.8.1. Company Overview
15.8.2. Product Offerings
15.8.3. Financial Performance
15.8.4. Recent Initiatives
15.9. Cellares
15.9.1. Company Overview
15.9.2. Product Offerings
15.9.3. Financial Performance
15.9.4. Recent Initiatives
15.10. Aldevron
15.10.1. Company Overview
15.10.2. Product Offerings
15.10.3. Financial Performance
15.10.4. Recent Initiatives
16.1. Primary Research
16.2. Secondary Research
16.3. Assumptions
17.1. About Us
17.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client